A pilot prospective safety trial of delivering anticoagulation therapy in children at risk of thrombocytopenia
Dr. Felipe Fajardo, PGY2
Supervisor: Dr. Mihir Bhatt
There is a lack of evidence surrounding the delivery of anticoagulant therapy (ACT) in the context of concurrent thrombocytopenia. This study is a prospective pilot study that will investigate the safety of delivering anticoagulant therapy (ACT) according to our institutional protocol for patients with a thromboembolism who are at risk for thrombocytopenia. This will provide further evidence for the safety of this protocol in assessing any major or clinically relevant non-major bleeds.
- To review the literature surrounding anti coagulation therapy and thrombocytopenia
- To discuss our plans for the prospective study assessing the safety of our institutional protocol regarding ACT and thrombocytopenia